Wed.Aug 28, 2024

article thumbnail

STAT+: UnitedHealth pledged a hands-off approach after buying a Connecticut medical group. Then it upended how doctors practice

STAT

MIDDLETOWN, Conn. — UnitedHealth Group told the Connecticut primary care doctors everything they wanted to hear. Take our money, the company said, and together we can bring about a future where primary care leads. A future where doctors can take better care of their patients, and reap the financial rewards of improved health. We’ll handle the business side while you look after your patients.

364
364
article thumbnail

After an FDA rejection, here’s what’s next in the psychedelics pipeline

PharmaVoice

By rejecting the first MDMA therapy earlier this month, the FDA signaled to the psychedelic drug sector that the road to approval isn’t clear cut.

337
337
Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

NIH launches $270 million anti-overdose research program for, and led by, Native Americans

STAT

Fatal drug overdoses shot up during the peak of Covid-19 in 2020. And as the dust settled on the pandemic, it quickly became clear that one demographic group had fared far worse than any other: Native Americans.  Now, to combat the drug crisis and its disproportionate impact on indigenous people, the federal government is launching an initiative specifically meant to bolster research into addiction and overdose within native communities.

331
331
article thumbnail

Bayer partners with RNA drugmaker to develop new cancer therapies

BioPharma Dive

Under a collaboration with NextRNA Therapeutics, Bayer will access the biotech’s platform to target long, non-coding RNA interactions with small molecule drugs.

114
114
article thumbnail

From Diagnosis to Delivery: How AI is Revolutionizing the Patient Experience

Speaker: Simran Kaur, Founder & CEO at Tattva Health Inc.

The healthcare landscape is being revolutionized by AI and cutting-edge digital technologies, reshaping how patients receive care and interact with providers. In this webinar led by Simran Kaur, we will explore how AI-driven solutions are enhancing patient communication, improving care quality, and empowering preventive and predictive medicine. You'll also learn how AI is streamlining healthcare processes, helping providers offer more efficient, personalized care and enabling faster, data-driven

article thumbnail

STAT+: Neurocrine reports mixed results on schizophrenia therapy in mid-stage trial

STAT

Neurocrine Biosciences said Wednesday that the lowest dose of an experimental pill for schizophrenia reduced psychosis reported by patients in a mid-stage study, but higher doses of the drug also tested were ineffective.  The company said the study results supported advancing the medicine into Phase 3 studies next year. Investors viewed the mixed data with more concern, sending Neurocrine’s stock down 18% in early trading.

293
293
article thumbnail

Novartis collaboration to innovate subcutaneous drug delivery

European Pharmaceutical Review

Novartis Pharma AG and biotech Lindy Biosciences have agreed to collaborate to advance subcutaneous biologic injectables. As part of a worldwide licensing agreement and collaboration, some of Novartis’ medicines will be developed into the injections via Lindy Biosciences’ proprietary microglassification suspension technology. This platform enables high concentrations of biologics to be delivered in a single dose, improving the convenience of administration and patient and treatment compliance, a

110
110

More Trending

article thumbnail

Neurocrine’s mixed schizophrenia data disappoint Wall Street

BioPharma Dive

Despite “positive” results, shares of the biotech slid by 20%. Analysts cautioned that Neurocrine shouldn’t get “the benefit of the doubt” with its data.

108
108
article thumbnail

Hims takes a blow from Lilly’s vial news

STAT

Good morning. As a treat for Labor Day weekend, we’re running a deal for STAT+ subscriptions. If you use the code LABORDAY at checkout, you can get 25% off your first year. Learn more here. Now onto the biotech news of the day.

article thumbnail

We like to think UK health services aren’t influenced by big money. That’s just not true | Margaret McCartney

The Guardian - Pharmaceutical Industry

There must be transparency over funding to medics from the pharmaceutical industry – and that’s only the start Shouldn’t we be able to trust doctors to give us independent advice? Earlier this year, there was an outcry when it appeared that a doctor who often appeared on TV to speak about Covid vaccines had been paid a significant sum by the pharmaceutical company AstraZeneca.

Vaccines 108
article thumbnail

STAT+: Pharmalittle: We’re reading about Zantac court cases, a Neurocrine schizophrenia pill, and more

STAT

Hello, everyone, and how are you today? We are doing just fine, thank you, especially since the middle of the week is upon us. After all, we have made it this far, so we are determined to hang on for another couple of days. And why not? The alternatives — at least those we can identify — are not so appetizing. And what better way to make the time fly than to keep busy.

198
198
article thumbnail

Why Every Small Business Needs an HCM Solution: A Comprehensive Guide

Managing HR tasks like payroll, compliance, and employee data can overwhelm small businesses. That’s where a Human Capital Management (HCM) solution comes in. Our eBook, Why Every Small Business Needs an HCM Solution: A Comprehensive Guide , shows how an HCM system automates tedious processes, ensuring your business stays compliant and efficient. You’ll learn how to simplify payroll, eliminate costly errors, and empower your employees with self-service tools.

article thumbnail

Puberty blockers can still be prescribed in some cases, says NHS England

The Pharmacist

Prescriptions can still be issued for puberty blockers for some children and young people if the prescriber 'feels competent to do so’, NHS England (NHSE) has said in new advice. It comes as the Government has recently extended the legal ban on private prescribing of puberty blockers, which was first introduced in May under the Conservatives, […] The post Puberty blockers can still be prescribed in some cases, says NHS England appeared first on The Pharmacist.

98
article thumbnail

Our investigation of UnitedHealth, explainer on Oropouche and news on maternal health

STAT

Want to stay on top of health news?  Sign up  to get our Morning Rounds newsletter in your inbox. Good morning! Amid today’s news, two items on pregnancy that are interesting and eerie to read in tandem. And on top of that, two itchy pieces of mosquito-related news from STAT’s Helen Branswell.

179
179
article thumbnail

Details emerge of £400m investment programme tied to VPAG

pharmaphorum

The £400m pledged by industry as part of the new VPAG voluntary scheme of pharma rebates will be used mainly to support the UK clinical research sector

113
113
article thumbnail

Pharmacist in practice: How a primary care ADHD service is 'life changing' for patients

The Pharmacist

Long waiting lists for adult ADHD services have led one GP practice to set up its own service, enabling patients to access diagnosis, titration and alternative prescriptions in the case of shortages through primary care. The Pharmacist spoke to one practice pharmacist involved. Kelvin Chan, a GP pharmacist based in Brighton, became interested in the […] The post Pharmacist in practice: How a primary care ADHD service is 'life changing' for patients appeared first on The Pharmacis

98
article thumbnail

Best Practices to Streamline Compensation Management: A Foundation for Growth

Speaker: Joe Sharpe and James Carlson

Payroll optimization can be one of the most time-consuming and complex factors of small business management. Yet, organizations that crack the code on streamlining employee compensation often discover innovative avenues for growth. With the right strategies in place, outsourcing and streamlining payroll processes can result in substantial time and resource savings.

article thumbnail

ACG Inspection awarded GS1 Nigeria certification as solution provider

Express Pharma

ACG Inspection, a track and trace solutions provider for the pharmaceutical industry, has been awarded a Certificate of Accreditation as a GS1 solution provider by GS1 Nigeria. This certification confirms that ACG Inspection meets the criteria set by GS1 Nigeria and conforms to its standards. As an official Gold Partner of GS1 Nigeria, ACG Inspection is positioned to assist businesses in achieving compliance with the regulations of the Nigerian National Agency for Food and Drug Administration an

99
article thumbnail

HDA 2024 Traceability Seminar: DSCSA Implementation and Readiness

Pharmaceutical Commerce

Session uncovers distributors’ experiences with the Waiver, Exception, or Exemption request process, and how these affect the overall supply chain.

104
104
article thumbnail

AI voice assistant can spot complications in heart patients

pharmaphorum

A virtual voice assistant used to contact patients after heart procedures can make early discharge possible and spot complications

112
112
article thumbnail

Biocon Biologics finalises agreement for Bmab 1200 market entry in Europe, UK, Canada, and Japan

Express Pharma

Biocon Biologics (BBL), a biosimilars company and subsidiary of Biocon announced today that it has signed a settlement and licence agreement with Janssen Biotech, Janssen Sciences Ireland, and Johnson & Johnson (collectively known as Janssen) for the global commercialisation of its biosimilar product Bmab 1200. Under the terms of the agreement, Biocon Biologics has resolved patent disputes with Janssen, securing market entry dates for Bmab 1200 in Europe, the UK, Canada, and Japan.

article thumbnail

Enhance Healthcare Efficiency With Top Payroll & HCM Services

Running a healthcare facility requires precision and care, not just for patients but also for your staff. Our guide, "A Buyer’s Guide to Payroll & HCM Services," helps healthcare providers choose the best provider. Efficient payroll management ensures timely, accurate payments, critical for maintaining staff morale and trust. Compliance support helps navigate complex healthcare regulations and avoid costly fines.

article thumbnail

Type 2 diabetes drug associated with 35% lower risk of dementia, study finds

The Guardian - Pharmaceutical Industry

Large Korean study suggests sodium-glucose cotransporter-2 inhibitors may prevent dementia A drug used to treat type 2 diabetes is associated with a 35% lower risk of dementia, according to research. The number of people with dementia globally is expected to nearly triple to 153 million by 2050. The health and social costs linked to dementia already exceed $1tn (£780bn) a year , research shows.

article thumbnail

Protect pharmacists' right to refuse involvement in assisted dying, says RPS

The Pharmacist

If assisted dying is introduced in Scotland, pharmacists must be able to conscientiously object to taking part, including by preparing, dispensing and supplying medication, the Royal Pharmaceutical Society (RPS) has said. It has called for an 'opt-in' section to be enshrined in law, and suggested that current provisions in the proposed legislation are unclear about […] The post Protect pharmacists' right to refuse involvement in assisted dying, says RPS appeared first on The Pharmacis

85
article thumbnail

myTomorrows and Pancreatic Cancer Europe partner on clinical trials

Pharma Times

The partnership will improve care for patients with pancreatic cancer

109
109
article thumbnail

Changing Faces – Board of Directors appointments from July 2024

pharmaphorum

Changing Faces announces new board of directors appointments from July 2024 for Immatics, Memo Therapeutics, Scancell, Abcuro and more. Stay updated on the latest developments in the biotech industry.

80
article thumbnail

Position Your Pharmacy for Expansion

Speaker: Chris Antypas and Josh Halladay

Access to limited distribution drugs and payer contracts are key to pharmacy expansion. But how do you prepare your operations to take the next step? Meaningful data: Collect and share clinical data regarding outcomes, utilization, and more Reporting: Limited distribution models require efficient tracking and reporting systems Workflows: Align workflows with specific pharma and payer contractual requirements For in-depth, expert insights on pharmacy expansion, watch this webinar from Inovalon.

article thumbnail

Acelyrin’s izokibep for hidradenitis suppurativa reveals positive results

Pharma Times

However the company will not continue developing the candidate

107
107
article thumbnail

Ghosting Potential Candidates? How This Could Be Ruining Your Reputation

The Script

Ghosting potential candidates can damage your organization's reputation! Our team at Rx relief explains in detail.

article thumbnail

Shifting the paradigm in pharma marketing with content transformation

pharmaphorum

Join the EVERSANA webinar to discover how content transformation is revolutionising pharma marketing strategies. Learn how to shift the paradigm and stay ahead in the industry.

67
article thumbnail

Avesthagen and Apollo AyurVAID partner to develop medical foods and dietary supplements

Express Pharma

Avesthagen and Apollo AyurVAID, a unit of Kerala First Health Services under the Apollo Hospitals Group, have announced a strategic partnership to design, validate, manufacture, and market a new range of medical foods and dietary supplements. The products, branded as “AvestaAyurVAID,” aim to integrate medical nutrition with Ayurvedic principles, addressing specific dietary management needs for various diseases and conditions.

article thumbnail

5 Reasons to Upgrade Your Pharmacy Management Software

Are you still using workarounds to manage your daily operations? To achieve peak performance, it's time to explore other options for specialty and infusion pharmacy software. Streamline pharmacy operations and improve clinical performance with automated processing, real-time data exchange, and electronic decision support. Download this helpful infographic to: Drive efficiency and patient adherence from referral receipt to delivery and ongoing care – all with our Pharmacy Cloud.

article thumbnail

Novartis builds case for Leqvio with monotherapy data

pharmaphorum

Novartis builds case for fast-growing cholesterol drug Leqvio, as V-MONO trial shows benefit as a monotherapy in patients at lower risk of heart disease

70
article thumbnail

HDA 2024 Traceability Seminar: What to Expect From FDA Inspections

Pharmaceutical Commerce

In an interview with Pharma Commerce Editor Nicholas Saraceno, Jeb Hunter, Senior Regulatory Consultant, EAS Consulting Group, discusses the on “What to Expect When They’re Inspecting: FDA Inspections on DSCSA Compliance" breakout session at the 2024 HDA Traceability Seminar.

59
article thumbnail

Leadership Appointments at RQM+

Pharmafile

Ronnie Mahofski and Kevin Rowland both become Executive Vice President and General Manager On August 27, MedTech service provider RQM+ announced their newest leadership appointments. Both Ronnie Mahofski and Kevin Rowland are promoted to executive vice president and general manager. Ronnie Mahofski joined the RQM+ team in 2015 where he excelled in key roles within Business […] The post Leadership Appointments at RQM+ appeared first on Pharmafile.

59
article thumbnail

Regulatory Considerations for API Manufacturing in the EU: Ensuring Compliance and Supply Chain Resilience

Drug Patent Watch

The European Union (EU) has implemented a robust regulatory framework to ensure the quality and safety of active pharmaceutical ingredients (APIs) used in medicines. The EU’s Good Manufacturing Practice (GMP) guidelines provide the minimum standards for API manufacturing, and compliance with these guidelines is mandatory for all manufacturers and importers of APIs intended for the EU market.

59
article thumbnail

Zuellig Pharma and Regeneron sign deal to supply Libtayo in South Korea and Taiwan

Pharmaceutical Business Review

A fully human monoclonal antibody, Libtayo acts on the immune checkpoint receptor PD-1 on T cells. It is said to be the first-line monotherapy approved for advanced non-small cell lung cancer (NSCLC). The drug is also used to treat metastatic or locally advanced cutaneous squamous cell carcinoma (CSCC) and recurrent or metastatic cervical cancer in South Korea.